XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Revenues    
Product revenues $ 962,881 $ 74,372
Costs and expenses    
Product costs 3,275,690 1,554,655
Sales and marketing 247,572 318,635
Research and development 167,189 500,620
General and administrative 2,376,236 1,785,510
Total costs and expenses 6,066,687 4,159,420
Operating loss (5,103,806) (4,085,048)
Other income (expense)    
Interest expense (75,288) (78,804)
Other income (expense), net 67,368 4,961
Total other income (expense) (7,920) (73,843)
Net loss (5,111,726) (4,158,891)
Other comprehensive income (loss):    
Foreign currency 82,905 80,039
Unrealized gains (114,065)  
Total other comprehensive income (loss) (31,160) 80,039
Comprehensive loss $ (5,142,886) $ (4,078,852)
Basic and diluted net loss per share $ (0.07) $ (0.06)
Weighted average number of common shares -    
basic and diluted 71,004,454 64,550,920